On the other hand, controversial results have been published on the effect of Gal-3 deficiency in models of hepatic steatosis/inflammation, with studies indicating either protection or increased disease severity in Gal-3 KO mice [9], [11], [12]. This evidence concerns the gene LGALS3 and Hepatic steatosis.